- Citations, last 5 years
- 63
- Works, last 5 years
- 9
- h-index
- 19
- Scientists listed
- 1
- Grants since 2016
- 8
Grants received
2020–2023 · cooperative agreement · U01
Safety and Immunogenicity of H3N2 M2SR monovalent influenza vaccine in older subjects
Pamuk Bilsel · FluGen (United States) · funded by National Institutes of Health
2020–2023 · cooperative agreement · U01
Safety and Immunogenicity of H3N2 M2SR monovalent influenza vaccine in older subjects
Pamuk Bilsel · FluGen (United States) · funded by National Institutes of Health
2020–2023 · cooperative agreement · U01
Safety and Immunogenicity of H3N2 M2SR monovalent influenza vaccine in older subjects
Pamuk Bilsel · FluGen (United States) · funded by National Institutes of Health
2015–2026 · grant · SB1
IND-enabling studies of an intranasal, single-replication M2SR influenza vaccine
Pamuk Bilsel · FluGen (United States) · funded by National Institutes of Health
2015–2026 · grant · SB1
IND-enabling studies of an intranasal, single-replication M2SR influenza vaccine
Pamuk Bilsel · FluGen (United States) · funded by National Institutes of Health
2015–2021 · research · R42
Restimulating memory T cell responses in elderly by a novel, live influenza vaccine
Pamuk Bilsel · FluGen (United States) · funded by National Institutes of Health
2015–2026 · grant · SB1
IND-enabling studies of an intranasal, single-replication M2SR influenza vaccine
Pamuk Bilsel · FluGen (United States) · funded by National Institutes of Health
2014–2021 · research · R44
Development of a novel highly effective influenza vaccine
Pamuk Bilsel · FluGen (United States) · funded by National Institutes of Health
